IL89124A - Composition for reducing immunoglobulin e response comprising an antagonist to human interleukin - 4 - Google Patents

Composition for reducing immunoglobulin e response comprising an antagonist to human interleukin - 4

Info

Publication number
IL89124A
IL89124A IL8912489A IL8912489A IL89124A IL 89124 A IL89124 A IL 89124A IL 8912489 A IL8912489 A IL 8912489A IL 8912489 A IL8912489 A IL 8912489A IL 89124 A IL89124 A IL 89124A
Authority
IL
Israel
Prior art keywords
composition
antagonist
human
human interleukin
monoclonal antibody
Prior art date
Application number
IL8912489A
Other languages
English (en)
Other versions
IL89124A0 (en
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22538655&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL89124(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of IL89124A0 publication Critical patent/IL89124A0/xx
Publication of IL89124A publication Critical patent/IL89124A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL8912489A 1988-02-02 1989-01-31 Composition for reducing immunoglobulin e response comprising an antagonist to human interleukin - 4 IL89124A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15141388A 1988-02-02 1988-02-02

Publications (2)

Publication Number Publication Date
IL89124A0 IL89124A0 (en) 1989-08-15
IL89124A true IL89124A (en) 1994-10-21

Family

ID=22538655

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8912489A IL89124A (en) 1988-02-02 1989-01-31 Composition for reducing immunoglobulin e response comprising an antagonist to human interleukin - 4

Country Status (20)

Country Link
US (1) US5676940A (pt)
EP (2) EP0327283B1 (pt)
JP (1) JPH03500050A (pt)
KR (1) KR900700132A (pt)
AT (1) ATE93144T1 (pt)
AU (1) AU629536B2 (pt)
CA (1) CA1341477C (pt)
DE (1) DE68908431T2 (pt)
DK (1) DK183590A (pt)
ES (1) ES2058490T3 (pt)
FI (1) FI903827A7 (pt)
HK (1) HK35196A (pt)
HU (1) HU211059B (pt)
IE (1) IE63097B1 (pt)
IL (1) IL89124A (pt)
MY (1) MY107079A (pt)
NZ (1) NZ227812A (pt)
PT (1) PT89573B (pt)
WO (1) WO1989006975A1 (pt)
ZA (1) ZA89766B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005183A1 (en) * 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
JPH0747547B2 (ja) * 1989-12-04 1995-05-24 シェリング・コーポレーション 敗血症性ショック治療用医薬組成物
WO1991009059A1 (en) * 1989-12-20 1991-06-27 Schering Corporation Antibody antagonists of human interleukin-4
US5252677A (en) * 1990-11-20 1993-10-12 Mitsubishi Petrochemical Company Limited Functionalized olefin polymers
DE4137333A1 (de) * 1991-11-13 1993-05-19 W Prof Dr Sebald Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US20020193575A1 (en) * 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US6911462B2 (en) 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6919366B2 (en) 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
PT2990420T (pt) 2000-05-26 2017-03-16 Immunex Corp Uso de anticorpos de recetor de interleucina-4 e composições dos mesmos
BR0208010A (pt) 2001-03-12 2004-12-21 Avanir Pharmaceuticals Composto de benzimidazol para modulação de ige e inibição de proliferação celular
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
US10196616B2 (en) 2017-02-15 2019-02-05 The United States Of America, As Represented By The Secretary Of Agriculture Altered avian virus for in-ovo inoculation and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
EP0255547A1 (en) * 1986-07-29 1988-02-10 Kishimoto, Tadamitsu, Prof. Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof
EP0617127A1 (en) * 1987-12-31 1994-09-28 Tanox Biosystems, Inc. Antigenic epitopes on B cell-bound IgE Immunoglobulins

Also Published As

Publication number Publication date
WO1989006975A1 (en) 1989-08-10
JPH03500050A (ja) 1991-01-10
FI903827A0 (fi) 1990-08-01
ZA89766B (en) 1989-09-27
IL89124A0 (en) 1989-08-15
NZ227812A (en) 1991-09-25
HUT54214A (en) 1991-01-28
HU891044D0 (en) 1990-11-28
HK35196A (en) 1996-03-08
IE63097B1 (en) 1995-03-22
KR900700132A (ko) 1990-08-11
CA1341477C (en) 2005-03-29
AU3038389A (en) 1989-08-25
DE68908431T2 (de) 1993-12-23
DK183590A (da) 1990-09-27
DE68908431D1 (de) 1993-09-23
DK183590D0 (da) 1990-08-01
HU211059B (en) 1995-10-30
MY107079A (en) 1995-09-30
US5676940A (en) 1997-10-14
PT89573A (pt) 1989-10-04
FI903827A7 (fi) 1990-08-01
EP0327283B1 (en) 1993-08-18
EP0397764A1 (en) 1990-11-22
IE890302L (en) 1989-08-02
AU629536B2 (en) 1992-10-08
ATE93144T1 (de) 1993-09-15
ES2058490T3 (es) 1994-11-01
EP0327283A1 (en) 1989-08-09
PT89573B (pt) 1994-01-31

Similar Documents

Publication Publication Date Title
EP0327283B1 (en) Method of reducing immunoglobulin e responses
EP1003781B1 (en) Interleukin-18 binding proteins, their preparation and use
US5096704A (en) Method of treating eosinophilia
KR100483494B1 (ko) 감마 인터페론에 대한 인간화 항체
CA2130436C (en) Cloning and expression of humanized monoclonal antibodies against human interleukin-4
JPH09510444A (ja) 自己免疫疾患の治療におけるｉｌ−１２およびｉｌ−１２アンタゴニストの使用
CA2002144C (en) Method of preventing or reducing eosinophilia
EP0504307B1 (en) Method of treating septic shock
US20070081975A1 (en) Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
AU650013B2 (en) BCRF1 antagonists for treating Epstein-Barr virus infections

Legal Events

Date Code Title Description
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed